In renal cell carcinoma, the luciferase assay method demonstrated that let-7f targets the KLK10, a subgroup of the Kallikreins family that is expressed in various normal organs such as breast, testis, ovary, kidney, and prostate with a diverse set of physiological functions[19,20]. Here, KLK4 is linked to renal cell carcinoma.